Clinical Trials Logo

Recurrent Lung Cancer clinical trials

View clinical trials related to Recurrent Lung Cancer.

Filter by:
  • None
  • Page 1

NCT ID: NCT03076164 Recruiting - Lung Cancer Clinical Trials

A Phase 1/2 Trial of Trametinib and Erlotinib in Patients With EGFR-Mutant Lung Adenocarcinomas and Acquired Resistance to Erlotinib

Start date: March 1, 2017
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine the safety, tolerability and overall response rate of trametinib when given in combination with erlotinib in patients with Stage IV or recurrent lung adenocarcinoma that cannot be treated with curative intent.